T

Thor Medical
TRMED

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NOK1.26B
EV
NOK1.04B
Shares Outstanding
361.03M
Beta
0.11
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E E
-
P/Revenue E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Thor Medical ASA

gainify

T

Thor Medical ASA

TRMED

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headq...

Sector

Healthcare

Industry

Biotechnology

CEO

Kurth, Jasper

Employees

13

IPO Date

2015-03-23

Headquarters

Drammensveien 167, Oslo, Oslo, 0277, Norway

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.